Abstract
Tenofovir is a nucleotide reverse transcriptase inhibitor for treatment of human immunodeficiency virus (HIV) infection. Several cases of renal failure associated with tenofovir therapy recently have been reported. A 54-year-old man with HIV experienced decreasing renal function and Fanconi's syndrome secondary to tenofovir therapy. His condition gradually improved after discontinuation of the drug. The available medical literature for reported cases of tenofovir-related nephrotoxicity indicates that this complication is apparently rare. However, our case report and literature review underscore the importance of monitoring renal function when treating patients with any nucleotide reverse transcriptase inhibitor.
Author supplied keywords
Cite
CITATION STYLE
James, C. W., Steinhaus, M. C., Szabo, S., & Dressler, R. M. (2004, March). Tenofovir-Related Nephrotoxicity: Case Report and Review of the Literature. Pharmacotherapy. https://doi.org/10.1592/phco.24.4.415.33182
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.